CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Can Technology Alone Tackle the Issue of Medicine Adherence?
Editorial Archive

Can Technology Alone Tackle the Issue of Medicine Adherence?

Though therapeutic treatments are generally trialled, approved and introduced based on the assumption of correct usage, actual patient adherence has been shown acros...
Continue Reading →
When Power Failure is Not an Option
Editorial Archive

When Power Failure is Not an Option

Smartphones and portable medical devices are being increasingly used together, raising the eyebrows of many in the industry. Here, Neil Oliver, Technical Marketing M...
Continue Reading →
A Review of Clinical Trial Challenges in Rare CNS Diseases
Clinical & Medical Research V7 I1

A Review of Clinical Trial Challenges in Rare CNS Diseases

Last year’s ice bucket challenge raised the profile of a rare CNS disease, amyotrophic lateral sclerosis (ALS), a form of motor neuron disease. There is a paucity of...
Continue Reading →
SUSAR Consolidation New Procurement Approach in Pharmacovigilance
Clinical & Medical Research V7 I1

SUSAR Consolidation New Procurement Approach in Pharmacovigilance

In the past three to five years, pharmacovigilance has witnessed a paradigm shift after release of guidelines by the US Food and Drug Administration (USFDA) and Euro...
Continue Reading →
Remote Diabetes Trial puts Patients at the Heart of Trial
Clinical & Medical Research V7 I1

Remote Diabetes Trial puts Patients at the Heart of Trial

Type 2 diabetes might just be the most dangerous non-communicable disease in the history of humankind, but putting patients in charge of their own care could help so...
Continue Reading →
Transparency: Turning Business Constraint into Commercial Advantage
Drug Discovery, Development & Delivery V7 I1

Transparency: Turning Business Constraint into Commercial Advantage

The pharmaceutical industry, one of the most crucial in the world in terms of impact on the lives of patients – from relieving pain to conquering disease – is in the...
Continue Reading →
Producing Colorectal Cancer Vaccine:  Combining Forces between Denmark and Estonia
Drug Discovery, Development & Delivery V7 I1

Producing Colorectal Cancer Vaccine: Combining Forces between Denmark and Estonia

Dr Eric Leire, M.D., MBA, Chief Executive Officer, president and director of the board of DanDrit Biotech USA, Inc, and Kairit Tints, Head of Quality and Qualified P...
Continue Reading →
RDD Europe 2015 Scientific Confernce
Drug Discovery, Development and Delivery

RDD Europe 2015 Scientific Confernce

Register now to attend the RDD Europe 2015 scientific conference, to be held May 5-8, 2015, in Antibes, France https://international-pharma.com/wp-content/uploads/20...
Continue Reading →
The Growing Prominence and Need of Patient Reported Outcomes
Editorial Archive

The Growing Prominence and Need of Patient Reported Outcomes

The challenge for pharmaceutical commercialisation no longer ends with regulatory approval; it intensifies after the approval. Today there is greater awareness about...
Continue Reading →
Creating a Culture of Trust and Breakthrough Innovation in Pharma
Editorial Archive

Creating a Culture of Trust and Breakthrough Innovation in Pharma

Today’s pharma industry is suffering a crisis of trust. It is grappling with a variety of issues that are affecting the industry’s performance and value and require ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026